Decoux, Antoine
Duron, Loic
Habert, Paul
Roblot, Victoire
Arsovic, Emina
Chassagnon, Guillaume
Arnoux, Armelle
Fournier, Laure
Funding for this research was provided by:
Fonds Unique Interministériel (DOS0066427/00)
PRAIRIE 3IA Institute (ANR19-P3IA-0001)
Article History
Received: 10 March 2023
Accepted: 30 July 2023
First Online: 28 August 2023
Competing interests
: LSF: General Electric Healthcare (Honoraria), Median Technologies (Honoraria), Sanofi (Honoraria), Guerbet (conference funding), Bristol-Myers-Squibb (research grant). GC: Chiesi SA (Honoraria), Gleamer (Honoraria), Guerbet (conference funding), Bayer (conference funding). The remaining authors have no conflicts of interest to declare.